Categories: NEWS

Nicola Caronzolo, Sintetica SA, Corporate CEO ,18.11

Nicola Caronzolo, Sintetica SA, Corporate CEO ,18.11

“My Path with Sintetica”

Special Keynote Speaker: Nicola Caronzolo, Corporate CEO, Sintetica SA

When: 18 November 5.45 PM

Where: Executive Center, USI

Nicola Caronzolo, Corporate CEO of Sintetica SA, headquartered in Mendrisio, Switzerland.

SINTETICA SA.

Established in 1921 and headquartered in Mendrisio, Sintetica is a Swiss pharmaceutical company delivering injectable medicines to patients worldwide, through innovative science and excellence in development, production and marketing.

Sintetica has developed a clear innovation strategy following patient needs and new sustainable pharma trends.

For more info, visit the website: https://sintetica.com/

Nicola Caronzolo.

I deeply love this company for which I have worked for 20 years with passion, energy and dedication. I love its nature, its history, the magical mix that we have been able to build, all together, between great professionalism in doing and deep respect in living.

After earning a Bachelor’s degree in Industrial Chemistry at the University of Milan, Nicola Caronzolo specialised in Polymer Science at the Giulio Natta School in Milan. A dual-national, Italian and Swiss, Nicola Caronzolo lives with his family in Lugano, Canton Ticino. After his studies, Mr. Caronzolo worked as an academic researcher at the University of Milan and afterwards for a company that manufactured polymeric support drugs. He joined Sintetica in 2002, when the company was beginning its progressive path of major expansion. He had an extensive career in the Industrial Affairs division and, after several years as Chief Operating Officer, he was appointed CEO of the company in February 2022. In his new role as CEO, Nicola Caronzolo intends to work to consolidate the major strategic directions of marketing Sintetica’s products in the most important global markets.
At the same time, he is committed to further strengthening the innovation sector, one of the hallmarks of this pharmaceutical company known for the quality of its products and its ability to innovate therapies by customising the answers to questions from professionals. What he finds fascinating is that such a growing company faces many challenges. Those challenges are determined by the company itself, and everyone works together to overcome them.

 

Book your place: emba@usi.ch

 

EmbaSt

Recent Posts

Executive MBA for career changers: how to transition successfully

An Executive MBA can be a powerful catalyst for career transitions, offering a structured pathway…

2 giorni ago

How to choose the right Executive MBA: 5 key criteria

When choosing the right program, professionals should evaluate 5 criteria: alignment with career goals, flexibility,…

2 giorni ago

Take advantage of 10% Early Bird Discount

USI EMBA offers a 10% early bird discount for June enrollment. The program focuses on…

1 settimana ago

What Is an Executive MBA? Everything You Need to Know

This article explains what an Executive MBA is, how it differs from a traditional MBA,…

1 settimana ago

The 8th Edition of Boldbrain Startup Challenge Kicks Off

The Boldbrain Startup Challenge, an acceleration program for early-stage startups, officially opens the call for…

2 settimane ago

Ethical Leadership in Business: how Executive MBAs are shaping the leaders of the future

In an era marked by complex and interconnected global challenges, the role of business leaders…

3 settimane ago